Release Date: 14/03/13 09:44 Summary: Non Renounceable Rights Issue Offer Document Price Sensitive: Yes Download Document 567.06KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%